A multiple sclerosis disease progression measure based on cumulative disability.
Ali ManouchehriniaElaine KingwellFeng ZhuHelen TremlettJan HillertRyan RamanujamPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
The nARMSS provides a reliable, generalizable and easily measurable metric which makes longitudinal comparison of disease course between individuals feasible.